Phase II Study of Atezolizumab + Bevacizumab in Endometrial Cancer
Clinical trial NCT03526432 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT03526432
- Sponsor
- University of Oklahoma
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2018-08-08
- Primary completion
- 2026-08-31
- Enrollment
- 110
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.